IGM Cash And Short Term Investments vs Cash Analysis

IGMS Stock

USD 1.36 0.02 1.49%

IGM Biosciences financial indicator trend analysis is infinitely more than just investigating IGM Biosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IGM Biosciences is a good investment. Please check the relationship between IGM Biosciences Cash And Short Term Investments and its Cash accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IGM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.

Cash And Short Term Investments vs Cash

Cash And Short Term Investments vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IGM Biosciences Cash And Short Term Investments account and Cash. At this time, the significance of the direction appears to have very strong relationship.

The correlation between IGM Biosciences' Cash And Short Term Investments and Cash is 0.89. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Cash in the same time period over historical financial statements of IGM Biosciences, assuming nothing else is changed. The correlation between historical values of IGM Biosciences' Cash And Short Term Investments and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of IGM Biosciences are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Cash And Short Term Investments i.e., IGM Biosciences' Cash And Short Term Investments and Cash go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of IGM Biosciences balance sheet. This account contains IGM Biosciences investments that will expire within one year. These investments include stocks and bonds that can be liquidated by IGM Biosciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Cash

Cash refers to the most liquid asset of IGM Biosciences, which is listed under current asset account on IGM Biosciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from IGM Biosciences customers. The amounts must be unrestricted with restricted cash listed in a different IGM Biosciences account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Most indicators from IGM Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IGM Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IGM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.At this time, IGM Biosciences' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 818.7 K in 2025, whereas Enterprise Value Over EBITDA is likely to drop (1.73) in 2025.

	2022	2023	2024	2025 (projected)
Reconciled Depreciation	6.1M	8.0M	9.2M	9.7M
Total Operating Expenses	229.0M	265.6M	305.4M	320.7M

Reconciled Depreciation Total Operating Expenses

IGM Biosciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other
Total Assets		0.81	0.88	-0.16	0.95	0.97	0.9	-0.75	-0.85	0.64	0.88	0.92	0.87	0.85	1.0	0.97	0.89	0.64	0.95	0.95	0.83	0.71	0.94	0.88	1.0	0.89
Other Current Liab	0.81		0.98	0.19	0.81	0.71	0.97	-0.41	-0.98	0.19	0.6	0.97	0.99	1.0	0.78	0.73	0.96	0.93	0.87	0.73	0.95	0.96	0.64	0.99	0.79	0.95
Total Current Liabilities	0.88	0.98		0.06	0.87	0.79	0.99	-0.54	-0.97	0.34	0.71	0.99	0.99	0.99	0.86	0.81	0.98	0.88	0.93	0.83	0.96	0.93	0.75	0.99	0.87	0.97
Total Stockholder Equity	-0.16	0.19	0.06		-0.06	-0.15	0.05	0.26	-0.2	-0.44	-0.2	0.05	0.07	0.13	-0.18	-0.17	0.14	0.28	-0.05	-0.41	0.15	0.24	-0.26	0.12	-0.18	0.0
Other Liab	0.95	0.81	0.87	-0.06		0.96	0.91	-0.73	-0.82	0.67	0.84	0.93	0.84	0.84	0.95	0.97	0.9	0.58	0.98	0.88	0.8	0.66	0.95	0.88	0.95	0.92
Net Tangible Assets	0.97	0.71	0.79	-0.15	0.96		0.83	-0.83	-0.75	0.77	0.92	0.85	0.76	0.75	0.98	0.98	0.84	0.48	0.94	0.91	0.75	0.56	0.98	0.8	0.98	0.83
Property Plant And Equipment Net	0.9	0.97	0.99	0.05	0.91	0.83		-0.59	-0.97	0.41	0.75	1.0	0.99	0.98	0.88	0.85	0.99	0.84	0.96	0.85	0.96	0.89	0.79	1.0	0.89	0.99
Net Debt	-0.75	-0.41	-0.54	0.26	-0.73	-0.83	-0.59		0.47	-0.92	-0.97	-0.58	-0.49	-0.47	-0.77	-0.75	-0.63	-0.17	-0.75	-0.78	-0.6	-0.26	-0.87	-0.54	-0.77	-0.56
Retained Earnings	-0.85	-0.98	-0.97	-0.2	-0.82	-0.75	-0.97	0.47		-0.24	-0.65	-0.96	-0.98	-0.98	-0.82	-0.78	-0.97	-0.9	-0.88	-0.75	-0.95	-0.94	-0.68	-0.98	-0.83	-0.95
Accounts Payable	0.64	0.19	0.34	-0.44	0.67	0.77	0.41	-0.92	-0.24		0.86	0.43	0.28	0.26	0.66	0.72	0.43	-0.11	0.64	0.68	0.35	-0.01	0.83	0.35	0.66	0.44
Cash	0.88	0.6	0.71	-0.2	0.84	0.92	0.75	-0.97	-0.65	0.86		0.75	0.67	0.66	0.89	0.86	0.78	0.37	0.88	0.87	0.75	0.45	0.93	0.71	0.89	0.73
Non Current Assets Total	0.92	0.97	0.99	0.05	0.93	0.85	1.0	-0.58	-0.96	0.43	0.75		0.98	0.98	0.9	0.87	0.98	0.82	0.97	0.85	0.94	0.87	0.81	0.99	0.9	0.99
Non Currrent Assets Other	0.87	0.99	0.99	0.07	0.84	0.76	0.99	-0.49	-0.98	0.28	0.67	0.98		1.0	0.84	0.78	0.97	0.91	0.91	0.82	0.96	0.95	0.71	0.99	0.85	0.96
Other Assets	0.85	1.0	0.99	0.13	0.84	0.75	0.98	-0.47	-0.98	0.26	0.66	0.98	1.0		0.83	0.77	0.97	0.92	0.9	0.79	0.96	0.95	0.69	0.99	0.83	0.96
Cash And Short Term Investments	1.0	0.78	0.86	-0.18	0.95	0.98	0.88	-0.77	-0.82	0.66	0.89	0.9	0.84	0.83		0.97	0.88	0.61	0.95	0.96	0.81	0.68	0.96	0.86	1.0	0.87
Common Stock Total Equity	0.97	0.73	0.81	-0.17	0.97	0.98	0.85	-0.75	-0.78	0.72	0.86	0.87	0.78	0.77	0.97		0.84	0.5	0.94	0.9	0.73	0.58	0.96	0.82	0.97	0.87
Common Stock Shares Outstanding	0.89	0.96	0.98	0.14	0.9	0.84	0.99	-0.63	-0.97	0.43	0.78	0.98	0.97	0.97	0.88	0.84		0.83	0.96	0.82	0.98	0.88	0.79	0.99	0.88	0.97
Non Current Liabilities Total	0.64	0.93	0.88	0.28	0.58	0.48	0.84	-0.17	-0.9	-0.11	0.37	0.82	0.91	0.92	0.61	0.5	0.83		0.66	0.57	0.86	0.99	0.4	0.87	0.62	0.78
Capital Surpluse	0.95	0.87	0.93	-0.05	0.98	0.94	0.96	-0.75	-0.88	0.64	0.88	0.97	0.91	0.9	0.95	0.94	0.96	0.66		0.9	0.9	0.74	0.92	0.94	0.95	0.96
Other Current Assets	0.95	0.73	0.83	-0.41	0.88	0.91	0.85	-0.78	-0.75	0.68	0.87	0.85	0.82	0.79	0.96	0.9	0.82	0.57	0.9		0.77	0.64	0.92	0.81	0.96	0.84
Other Stockholder Equity	0.83	0.95	0.96	0.15	0.8	0.75	0.96	-0.6	-0.95	0.35	0.75	0.94	0.96	0.96	0.81	0.73	0.98	0.86	0.9	0.77		0.9	0.69	0.97	0.81	0.92
Total Liab	0.71	0.96	0.93	0.24	0.66	0.56	0.89	-0.26	-0.94	-0.01	0.45	0.87	0.95	0.95	0.68	0.58	0.88	0.99	0.74	0.64	0.9		0.48	0.91	0.68	0.84
Net Invested Capital	0.94	0.64	0.75	-0.26	0.95	0.98	0.79	-0.87	-0.68	0.83	0.93	0.81	0.71	0.69	0.96	0.96	0.79	0.4	0.92	0.92	0.69	0.48		0.75	0.95	0.8
Property Plant And Equipment Gross	0.88	0.99	0.99	0.12	0.88	0.8	1.0	-0.54	-0.98	0.35	0.71	0.99	0.99	0.99	0.86	0.82	0.99	0.87	0.94	0.81	0.97	0.91	0.75		0.86	0.98
Total Current Assets	1.0	0.79	0.87	-0.18	0.95	0.98	0.89	-0.77	-0.83	0.66	0.89	0.9	0.85	0.83	1.0	0.97	0.88	0.62	0.95	0.96	0.81	0.68	0.95	0.86		0.88
Non Current Liabilities Other	0.89	0.95	0.97	0.0	0.92	0.83	0.99	-0.56	-0.95	0.44	0.73	0.99	0.96	0.96	0.87	0.87	0.97	0.78	0.96	0.84	0.92	0.84	0.8	0.98	0.88

Click cells to compare fundamentals

IGM Biosciences Account Relationship Matchups

IGM Biosciences fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	408.6M	298.1M	513.5M	423.4M	486.9M	300.2M
Other Current Liab	4.0M	15.6M	27.8M	31.5M	36.3M	38.1M
Total Current Liabilities	17.2M	27.8M	44.7M	42.5M	48.9M	51.3M
Total Stockholder Equity	(188.6M)	(353.7M)	(574.8M)	203.2M	182.9M	192.1M
Net Tangible Assets	240.2M	381.8M	244.9M	287.3M	330.4M	192.1M
Property Plant And Equipment Net	34.8M	56.3M	73.1M	74.0M	85.1M	89.4M
Net Debt	(228.8M)	(104.6M)	(80.1M)	(72.0M)	(64.8M)	(68.1M)
Retained Earnings	(188.6M)	(353.7M)	(574.8M)	(821.2M)	(739.1M)	(702.2M)
Accounts Payable	7.9M	5.6M	2.5M	1.3M	1.5M	1.4M
Cash	241.1M	133.3M	121.2M	112.5M	129.4M	101.6M
Non Current Assets Total	35.4M	57.4M	75.1M	75.8M	87.2M	91.5M
Non Currrent Assets Other	548K	1.0M	2.0M	1.8M	2.1M	2.2M
Other Assets	258K	548K	1.0M	2.0M	2.3M	2.4M
Cash And Short Term Investments	366.3M	229.5M	427.2M	337.7M	388.3M	251.4M
Common Stock Shares Outstanding	30.7M	33.5M	41.5M	52.3M	60.2M	63.2M
Short Term Investments	125.2M	96.2M	305.9M	225.2M	258.9M	147.9M
Liabilities And Stockholders Equity	(161.7M)	(300.5M)	(348.6M)	423.4M	486.9M	511.3M
Non Current Liabilities Total	9.6M	25.4M	181.6M	177.7M	204.4M	214.6M
Capital Surpluse	751K	347.1M	570.0M	598.4M	688.1M	722.5M
Capital Lease Obligations	12.2M	28.8M	41.2M	40.5M	46.6M	48.9M
Other Current Assets	14.0M	11.2M	21.3M	9.9M	11.4M	10.0M
Other Stockholder Equity	570.0M	598.4M	862.4M	1.0B	1.2B	1.2B
Total Liab	26.8M	53.2M	226.2M	220.2M	253.2M	265.9M
Net Invested Capital	381.8M	244.9M	287.3M	203.2M	233.7M	197.4M
Property Plant And Equipment Gross	34.8M	62.9M	85.4M	94.6M	108.8M	114.2M
Total Current Assets	373.3M	240.7M	438.4M	347.6M	399.7M	256.8M
Accumulated Other Comprehensive Income	26K	(66K)	(701K)	151K	173.7K	182.3K
Net Working Capital	356.0M	213.0M	393.7M	305.1M	350.9M	233.1M
Short Term Debt	5.3M	6.6M	11.6M	5.8M	6.7M	5.8M
Common Stock	319K	325K	431K	331K	380.7K	270.0K
Property Plant Equipment	18.0M	34.8M	28.5M	73.1M	84.0M	88.2M
Short Long Term Debt Total	12.2M	28.8M	41.2M	40.5M	46.6M	26.1M
Capital Stock	319K	325K	431K	586K	673.9K	361.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for IGM Stock Analysis

When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC